These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 8752682)

  • 1. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome].
    Kuwabara S; Nakajima M; Moroo I; Hirayama K
    Rinsho Shinkeigaku; 1996 Feb; 36(2):289-92. PubMed ID: 8752682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
    Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
    Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
    Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
    Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.
    Neurology; 1985 Aug; 35(8):1096-104. PubMed ID: 4022342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of the Guillain-Barré syndrome in childhood by plasmapheresis].
    Hernández González A; Rubio Quiñones F; Quintero Otero S; Cozar Navarro L; Cañibano MA; Capote Huelva FJ; Alvarez C; Pantoja Rosso S
    An Esp Pediatr; 1993 Sep; 39(3):240-2. PubMed ID: 8250439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis for Guillain-Barré syndrome: evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis.
    Cheng BC; Chang WN; Chen JB; Chee EC; Huang CR; Lu CH; Chang CJ; Hung PL; Chuang YC; Lee CT; Lee PY; Wang KW; Chang HW
    J Clin Apher; 2003; 18(4):175-80. PubMed ID: 14699593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of plasmapheresis in childhood Guillain-Barré syndrome.
    Epstein MA; Sladky JT
    Ann Neurol; 1990 Jul; 28(1):65-9. PubMed ID: 2375635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis].
    Fasanaro AM; Pizza V; Florio C; Tancredi G; Fabbri P; Aiello L; Viscidi E; Rossi V; Vacca C
    Riv Neurol; 1991; 61(1):39-45. PubMed ID: 1857922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of plasmapheresis and other immunomodulating therapies on the course of severe Guillain-Barré syndrome].
    Hidasi E; Soltész P
    Orv Hetil; 2001 Feb; 142(7):335-9. PubMed ID: 11243015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing outcome in Guillain-Barré Syndrome: comparison of plasma adsorption against other treatments.
    Seta T; Nagayama H; Katsura K; Hamamoto M; Araki T; Yokochi M; Utsumi K; Katayama Y
    Clin Neurol Neurosurg; 2005 Oct; 107(6):491-6. PubMed ID: 16202823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Removal ability of anti-ganglioside antibodies in immunoadsorption using a modified tryptophan-immobilized column].
    Tagawa Y; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1997 Oct; 37(10):863-7. PubMed ID: 9490893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasmapheresis and hormone therapy in severe forms of Guillain-Barré syndrome].
    Levchenko NI; Piradov MA; Pirogov VN
    Klin Med (Mosk); 1989 Dec; 67(12):88-91. PubMed ID: 2560799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical use of IM-PH immuno-columns].
    Maresca MC; Da Porto A; Cusumano S; Serena M
    Ann Med Interne (Paris); 1988; 139 Suppl 1():69-71. PubMed ID: 2854714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IgM antibody against sulfated glucuronyl paragloboside in a case of Guillain-Barré syndrome].
    Yoshino H; Shibata S; Arita M
    Rinsho Shinkeigaku; 1996 Aug; 36(8):990-2. PubMed ID: 8958754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasmapheresis therapy in Guillain-Barré polyneuroradiculitis].
    Zwahlen H; Quadri F; Mombelli G; Tatti V; Marone C
    Schweiz Med Wochenschr; 1988 Dec; 118(49):1854-8. PubMed ID: 3217776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of anti-glycolipid antibody-associated neuropathy].
    Yuki N
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1232-4. PubMed ID: 10791085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.